Form 8-K - Current report:
SEC Accession No. 0001641172-25-018877
Filing Date
2025-07-14
Accepted
2025-07-14 06:30:34
Documents
20
Period of Report
2025-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 217694
2 EX-2.1 ex2-1.htm EX-2.1 1519182
3 EX-3.1 ex3-1.htm EX-3.1 118400
4 EX-4.1 ex4-1.htm EX-4.1 140158
5 EX-10.1 ex10-1.htm EX-10.1 90007
6 EX-10.2 ex10-2.htm EX-10.2 98783
7 EX-10.3 ex10-3.htm EX-10.3 295697
8 EX-99.1 ex99-1.htm EX-99.1 39945
9 GRAPHIC ex99-1_001.jpg GRAPHIC 22980
  Complete submission text file 0001641172-25-018877.txt   3210931

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE sonn-20250711.xsd EX-101.SCH 3017
11 XBRL LABEL FILE sonn-20250711_lab.xml EX-101.LAB 34239
12 XBRL PRESENTATION FILE sonn-20250711_pre.xml EX-101.PRE 22360
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3812
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 251120105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)